If you are looking for short-term momentum, these stocks have seen recent significant price surges as of late April 2026: Recently jumped over 47%.

These are often recommended for multi-decade portfolios due to their resilient business models.

Favored for its long-term growth in the diabetes and weight-loss drug markets.

Cited by Morningstar as a significantly undervalued "wide moat" company.